OXYPHENBUTAZONE (“TANDERIL”, G 27202): AN ANTIRHEUMATIC DERIVATIVE OF PHENYLBUTAZONE
- 1 June 1961
- journal article
- Published by AMPCo in The Medical Journal of Australia
- Vol. 1 (23) , 851-853
- https://doi.org/10.5694/j.1326-5377.1961.tb69240.x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- DENMARKJAMA, 1960
- Long-term Use of Phenylbutazone in Rheumatoid ArthritisBMJ, 1960
- Phenylbutazone as a therapeutic agent in rheumatic diseases: Its present statusArthritis & Rheumatism, 1960
- The clinical evaluation of a new anti-inflammatory agent: A preliminary reportThe American Journal of Surgery, 1959
- The comparative effects of phenylbutazone and G27202 (metabolite i) in patients with rheumatoid arthritis: An assessment of methods for antirheumatic drug evaluationArthritis & Rheumatism, 1959
- Untoward effects of phenylbutazone (butazolidin)–A re-evaluationArthritis & Rheumatism, 1959
- Phenylbutazone and its DerivativesBMJ, 1959
- Phenylbutazone and Its DerivativesBMJ, 1959
- Über Derivate des Phenylbutazons. I. In den Benzolkernen hydroxylierte DerivateHelvetica Chimica Acta, 1957